Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications

<p style="text-align:justify;"> Endogenous damage-associated molecular patterns (DAMPs) are released during tissue damage and have increasingly recognized roles in the etiology of many human diseases. The inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn’s disease...

书目详细资料
Main Authors:	Boyapati, R, Rossi, A, Satsangi, J, Ho, G
格式:	Journal article
出版:	Springer Nature 2016

相似书籍

Biomarkers in search of precision medicine in IBD
由: Boyapati, R, et al.
出版: (2016)

Mitochondrial DNA is a pro-inflammatory damage-associated molecular pattern released during active IBD
由: Boyapati, R, et al.
出版: (2018)

Regulation of Mucosal Immune Responses – The Missing Link in IBD?
由: Charles O Elson, et al.
出版: (1996-01-01)

MicroRNAs: new players in IBD
由: Kalla, R, et al.
出版: (2014)

TNF Promoter Hypomethylation Is Associated With Mucosal Inflammation in IBD and Anti-TNF Response
由: Daniel S. Levic, et al.
出版: (2024-01-01)

Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD
由: Adams, A, et al.
出版: (2017)

The Gut-Brain Axis in IBD: An Investigator’s Perspective
由: Stephen M Collins, et al.
出版: (1995-01-01)

Top-down in the long term in Crohn's disease
由: Boyapati, R, et al.
出版: (2018)

Editorial: what can be done when infliximab stops working in ulcerative colitis?
由: Boyapati, R, et al.
出版: (2015)

Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD
由: Paul F. Miller
出版: (2024-08-01)

Can thiopurines prevent formation of antibodies against tumor necrosis factor antagonists after failure of these therapies?
由: Boyapati, RK, et al.
出版: (2016)

Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization
由: Wei Yang, et al.
出版: (2025-01-01)

Extracellular Vesicles with Possible Roles in Gut Intestinal Tract Homeostasis and IBD
由: Xin Chang, et al.
出版: (2020-01-01)

Neutrophils: Old cells in IBD, new actors in interactions with the gut microbiota
由: Camille Danne
出版: (2024-06-01)

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review
由: Wiktoria Maria Tomaszewska, et al.
出版: (2025-01-01)

The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease.
由: Parkes, M, et al.
出版: (2000)

SARS-CoV-2 vaccination in IBD: past lessons, current evidence and future challenges
由: Wellens, J, et al.
出版: (2021)

How to apply for and secure EU funding for collaborative IBD research projects
由: Satsangi, J, et al.
出版: (2016)

Gut microbiota in MAFLD: therapeutic and diagnostic implications
由: Waleed Alghamdi, et al.
出版: (2024-04-01)

Mediators of Gut Mucosal Immunity and Inflammation
由: Ishak Ozel Tekin, et al.
出版: (2015-01-01)

Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis
由: Adrian Rotaru, et al.
出版: (2025-02-01)

Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
由: Yinping Pan, et al.
出版: (2024-12-01)

Leaky gut, circulating immune complexes, arthralgia, and arthritis in IBD: coincidence or inevitability?
由: Xi-ya Jin, et al.
出版: (2024-03-01)

Anti-SARS-CoV-2 antibody responses in patients with IBD treated with biologics - are we finding CLARITY?
由: Chapman, TP, et al.
出版: (2021)

Therapeutic Potential of Tolerogenic Dendritic Cells in IBD: From Animal Models to Clinical Application
由: Raquel Cabezón, et al.
出版: (2013-01-01)

IBD and Diet
由: Ilene Gilbert, et al.
出版: (1994-01-01)

IBD and IBS : novel mechanisms and future practice /
由: Falk Symposium (170th : 2009 : Glasgow, Scotland), et al.
出版: (c201)

The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn’s disease
由: Noble, C, et al.
出版: (2005)

Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches
由: Lucia Centanni, et al.
出版: (2025-01-01)

Lactococcus lactis, A Tool for the Delivery of Therapeutic Proteins Treatment of IBD
由: Lothar Steidler
出版: (2001-01-01)

Year in microbiota: IBD clinical studies
由: T. Jayawardana, et al.
出版: (2023-10-01)

Neuromodulation and the Gut–Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders
由: Baha’ Aljeradat, et al.
出版: (2024-05-01)

Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response
由: Joshua B. Simpson, et al.
出版: (2023-12-01)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
由: Jessica Mwinyi, et al.
出版: (2012-01-01)

IBD: Progress in Pathogenesis
由: Claudio Fiocchi, et al.
出版: (1993-01-01)

Etiology of Organ-Specific Autoimmunity: Basic Research and Clinical Implications in IBD
由: George S Eisenbarth
出版: (1996-01-01)

Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC
由: Sushma S. Kumar, et al.
出版: (2024-04-01)

Biosimilars in IBD: hope or expectation?
由: Gecse, K, et al.
出版: (2013)

Validation of the Portuguese Version of IBD-Control Questionnaire and Comparison with IBD-Disk
由: Tânia Carvalho, et al.
出版: (2024-10-01)

The Role of IL-33 in Gut Mucosal Inflammation
由: Luca Pastorelli, et al.
出版: (2013-01-01)